Taiwan offers significant opportunities for UK life sciences, pharmaceutical and medical device companies, supported by a sophisticated healthcare system, strong demand for innovative healthcare solutions, and growing UK-Taiwan trade links. Notably, pharmaceutical products remain the UK's largest goods export category to Taiwan, highlighting the strength of commercial engagement between the two markets. Besides, in 2026, Taiwan once again ranks No. 1 in the Health Care Index by Country, maintaining its leading position globally for consecutive years.
Delivered in partnership with RAPS Taiwan, this webinar will provide UK exporters with a practical introduction to Taiwan's healthcare regulatory landscape and market entry process. Participants will gain insights into regulatory requirements for pharmaceuticals and medical devices, market access considerations, product registration pathways, healthcare reimbursement, and key factors for successful market entry.
The session is designed for UK businesses exploring opportunities in Taiwan or seeking to expand their presence in the market, helping them better understand the regulatory environment and identify routes to commercial success in one of Asia's most advanced healthcare markets.
